{"id":1219,"date":"2025-11-21T06:04:52","date_gmt":"2025-11-21T06:04:52","guid":{"rendered":"https:\/\/snips.nutrifytoday.com\/blog\/?p=1219"},"modified":"2025-11-21T06:04:52","modified_gmt":"2025-11-21T06:04:52","slug":"a-dual-action-peptide-for-visceral-fat-reduction-and-sleep-quality-enhancement-in-obese-adults","status":"publish","type":"post","link":"https:\/\/snips.nutrifytoday.com\/blog\/a-dual-action-peptide-for-visceral-fat-reduction-and-sleep-quality-enhancement-in-obese-adults\/","title":{"rendered":"A Dual-Action Peptide for Visceral Fat Reduction and Sleep Quality Enhancement in Obese Adults"},"content":{"rendered":"\n<p>Pep19 (DIIADDEPLT) is a novel, orally active peptide identified as an inverse agonist of the cannabinoid type 1 (CB1) receptor, showing promising dual-action benefits in metabolic health and sleep quality. In a 60-day, triple-blind, placebo-controlled clinical trial involving obese adults (BMI 30\u201335), daily supplementation with 5 mg Pep19 led to a significant 17% reduction in visceral fat without affecting lean mass. Additionally, both 2 mg and 5 mg doses improved sleep quality by up to 35%, alongside measurable reductions in waist circumference and body weight. The peptide was well tolerated, with no reported adverse effects, suggesting its potential as a safe and effective solution for managing abdominal obesity and enhancing quality of life.<\/p>\n\n\n\n<p>Source: <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dmrr.70056\" target=\"_blank\" rel=\"noreferrer noopener\">Pep19: A Novel Approach for Reducing Visceral Fat and Improving Sleep Quality in Obese Adults\u2014Results From an Early\u2010Stage Clinical Trial &#8211; Heimann &#8211; 2025 &#8211; Diabetes\/Metabolism Research and Reviews &#8211; Wiley Online Library<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pep19 (DIIADDEPLT) is a novel, orally active peptide identified as an inverse agonist of the cannabinoid type 1 (CB1) receptor, showing promising dual-action benefits in metabolic health and sleep quality. In a 60-day, triple-blind, placebo-controlled clinical trial involving obese adults (BMI 30\u201335), daily supplementation with 5 mg Pep19 led to a significant 17% reduction in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1219","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/comments?post=1219"}],"version-history":[{"count":1,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1219\/revisions"}],"predecessor-version":[{"id":1220,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1219\/revisions\/1220"}],"wp:attachment":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/media?parent=1219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/categories?post=1219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/tags?post=1219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}